Just been looking at some interesting moves from one of the top-performing hedge fund managers in the market, and there's a pattern worth paying attention to. John Kim, who runs Night Owl Capital Management, has been quietly building positions in three major stocks that caught my eye: UnitedHealth, Fiserv, and Visa.

Kim's track record speaks for itself. The guy ranks fifth among hundreds of fund managers tracked by major financial platforms, with cumulative gains over 335% since early 2016. His Sharpe ratio sits at 4.9, which basically means his returns significantly outpace the risk he's taking. That's the kind of metric that gets my attention.

Let's start with UnitedHealth. Kim bumped up his stake by over 12% in the first quarter, and it now represents about 4.23% of his portfolio. The healthcare space has been interesting lately, and UnitedHealth's position in both insurance and healthcare services gives it solid footing. The company's cash position is strong enough to pursue strategic acquisitions, and their push into AI-driven solutions and customer expansion feels like the right move for where healthcare is heading. Analysts are pretty bullish here, with consensus showing strong buy ratings and price targets suggesting roughly 17-18% upside from where things stood.

Then there's Fiserv. Kim increased his holdings by just over 10%, bringing it to 5.07% of his portfolio. This is a fintech story that makes sense. Their small business payment solutions and expansion into value-added services position them well for the next cycle. With inflation cooling, consumer spending typically picks up, which would be a tailwind for a company like this. The analyst consensus is similarly strong, with price targets implying roughly 17% upside potential.

Visa rounds out the trio. Kim's position here grew by about 2.31%, now sitting at 5.3% of his portfolio. The payments space has been resilient, and cross-border travel rebounding is a real tailwind. Visa's track record of innovating in payments and rolling out new services keeps them relevant in a shifting landscape. Analyst price targets suggest around 14% upside from where the stock was trading.

What strikes me about these three picks is they're not contrarian bets. They're solid, established names with real business momentum. When someone like Kim is quietly adding to positions in quality companies like these, it's worth noting. Whether you're looking at healthcare infrastructure, fintech payments, or global transaction networks, these represent exposure to some pretty fundamental secular trends. The fact that all three are showing analyst conviction around their growth prospects makes this a portfolio setup worth understanding, even if you're just trying to understand where smart money is thinking.